Viewing Study NCT01597492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-01-25 @ 11:12 PM
Study NCT ID: NCT01597492
Status: COMPLETED
Last Update Posted: 2018-08-16
First Post: 2012-05-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Sponsor: Human Genome Sciences Inc., a GSK Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antibodies View
None Vaccines View
None SLE View
None Immune System Diseases View
None Biological Therapy View
None Autoimmune Diseases View
None Pneumococcal Vaccines View
None Lupus View
None Immunoglobulins View
None Vaccination View
None Belimumab View
None Biological Agents View
None Immunization View